Mode
Text Size
Log in / Sign up

vancomycin

12 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of vancomycin

62 trials tracked of vancomycin: 35 in phase 3 or 4 and 14 with published results. The most-cited published study has 105 citations.

62Trials tracked
35Phase 3 & 4
0Recruiting
14With published results
Phase distribution
Phase 4 13 Phase 3 22 Phase 2 15 Phase 1 3 Other / NA 9
  1. Phase 3 Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections Completed · 105 cited
  2. Phase 3 Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections Completed · 103 cited
  3. Phase 3 Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-005) Completed · 72 cited
  4. Phase 3 A Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-006) Completed · 71 cited
  5. Phase 3 Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea Completed · 65 cited
  6. Phase 3 Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile - Associated Diarrhea Completed · 65 cited
Show 44 more trials
  1. Phase 3 Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1 Completed · 49 cited
  2. Phase 3 Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-2 Completed · 38 cited
  3. Phase 4 Study to Assess Inhibition of Spore Production in Patients With C. Difficile Infections: Fidaxomicin Versus Vancomycin Completed · 32 cited
  4. Phase 3 Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection Completed · 32 cited
  5. Phase 3 Regional Prophylactic Vancomycin With Restricted Tourniquet Time in Primary Total Knee Replacement Completed · 31 cited
  6. Phase 4 A Comparison of Fidaxomicin and Vancomycin in Patients With CDI Receiving Antibiotics for Concurrent Infections Completed · 16 cited
  7. Phase 4 Impact of Oral Antibiotic Treatment on C. Difficile Completed · 15 cited
  8. Phase 3 Topical Vancomycin for Neurosurgery Wound Prophylaxis Completed · 8 cited
  9. Phase 4 A Randomized Trial of Preoperative Prophylactic Antibiotics Prior to Kidney Stone Surgery (Percutaneous Nephrolithotomy [PCNL]) Completed
  10. Phase 4 Preoperative Antibiotics for Carpal Tunnel Release Surgery Completed
  11. Phase 4 Responses to Rabies Vaccine in Adults With or Without Antibiotics Completed
  12. Phase 4 Screening to Prophylax Against Clostridium Difficile Infection - Completed
  13. Phase 4 Acute Application of Antibiotic Powder in Open Fracture Wounds Completed
  14. Phase 4 Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA Completed
  15. Phase 4 Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA) Completed
  16. Phase 4 Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections Completed
  17. Phase 4 Effect of Probiotic Supplementation on Endothelial Function Completed
  18. Phase 4 Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA) Completed
  19. Phase 3 Regional Prophylactic Vancomycin in Revision Total Knee Replacement Completed
  20. Phase 3 A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) Completed
  21. Phase 3 Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA Completed
  22. Phase 3 Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus Completed
  23. Phase 3 Fidaxomicin Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) (MK-5119-018) Completed
  24. Phase 3 PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) Completed
  25. Phase 3 Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus Completed
  26. Phase 3 China Registration Study in Patients With Skin Infections Completed
  27. Phase 3 Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus Completed
  28. Phase 3 Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus Completed
  29. Phase 3 Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections Completed
  30. Phase 2 Investigation of the Gut Microbiota in Regulating Nutrient Absorption in Humans Completed
  31. Phase 2 Topical Antibiotics in Chronic Rhinosinusitis Completed
  32. Phase 2 ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection Completed
  33. Phase 2 The Effect of an Antibiotic on the Production of Uremic Toxins by the Gut Microbiome Completed
  34. Phase 2 A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections Completed
  35. Phase 2 Study of CB-183,315 in Participants With Clostridium Difficile Infection Completed
  36. Phase 2 Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI) Completed
  37. Phase 2 DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia Completed
  38. Phase 2 Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection Completed
  39. Phase 2 Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease Completed
  40. Phase 2 PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN Completed
  41. Phase 2 TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection Completed
  42. Phase 2 Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci Completed
  43. Phase 2 Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection Completed
  44. Phase 2 Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease Completed

Showing the 50 most-cited and recently-updated of 62 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.